InvestorsObserver
×
News Home

Should Zogenix, Inc. (ZGNX) be in Your Portfolio?

Tuesday, September 29, 2020 02:46 PM | InvestorsObserver Analysts

Mentioned in this article

Should Zogenix, Inc. (ZGNX) be in Your Portfolio?

Zogenix, Inc. (ZGNX) is around the bottom of the Biotechnology industry according to InvestorsObserver. ZGNX received an overall rating of 36, which means that it scores higher than 36 percent of all stocks. Zogenix, Inc. also achieved a score of 25 in the Biotechnology industry, putting it above 25 percent of Biotechnology stocks. Biotechnology is ranked 28 out of the 148 industries.

Overall Score - 36
ZGNX has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on ZGNX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Zogenix, Inc. Stock Today?

Zogenix, Inc. (ZGNX) stock is trading at $17.65 as of 2:15 PM on Tuesday, Sep 29, a drop of -$0.35, or -1.94% from the previous closing price of $18.00. The stock has traded between $17.48 and $18.44 so far today. Volume today is below average. So far 857,547 shares have traded compared to average volume of 1,451,424 shares.

Click Here to get the full Stock Score Report on Zogenix, Inc. (ZGNX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App